Literature DB >> 8254407

Thallium-201 myocardial SPECT in Bland-White-Garland syndrome: two adult patients with inferoposterior perfusion defect.

M Katsuragi1, K Yamamoto, T Tashiro, H Nishihara, K Toudou.   

Abstract

A myocardial 201TI SPECT examination was conducted both prior to and following surgery of two adult patients with an anomalous left coronary artery originating from the pulmonary artery (Bland-White-Garland syndrome). In this syndrome, the anterior wall is usually affected first. Preoperative examination demonstrated an inferoposterior perfusion defect. In both patients, the right coronary artery was markedly dilated, and a significant left-to-right shunt formation was observed. Both patients were diagnosed as possibly having coronary steal syndrome. A prolonged inadequate blood supply to the right coronary region may cause inferoposterior cardiomyopathy. In the postoperative examination, myocardial perfusion markedly improved in one patient whose preoperative SPECT showed redistribution in a delayed scan. Thallium-201 SPECT was therefore found to be useful in assessing both the preoperative and postoperative myocardial perfusion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254407

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

1.  [Resuscitation in ventricular fibrillation as the first manifestation of Bland-White-Garland syndrome in adulthood].

Authors:  C Weiss; S Willems; T Hofmann; C Rickers; T Meinertz
Journal:  Med Klin (Munich)       Date:  1997-07-15

2.  Bland-White-Garland syndrome and atrial septal defect - rare association and diagnostic challenge.

Authors:  T Schneider; H Rickli; V Gliech; M Maeder
Journal:  Clin Res Cardiol       Date:  2006-03-08       Impact factor: 6.138

3.  Nicorandil was an Effective Treatment Option for a Patient with Bland-White-Garland Syndrome.

Authors:  Shun Morishita; Hirofumi Maeba; Kazuya Takehana; Ichiro Shiojima
Journal:  Intern Med       Date:  2017-08-10       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.